Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
VanEck Semiconductor ETF
SMH
Invesco Solar ETF
TAN
4
The Technology Select Sector SPDR® Fund
XLK
5
SPDR S&P Metals & Mining ETF
XME
US Stock MarketDetailed Quotes
Neurogene (NGNE)
- 26.140
- -1.400-5.08%
Close Jun 2 16:00 ET
- 26.530
- +0.390+1.49%
Pre 05:34 ET
413.06MMarket Cap-5.75P/E (TTM)
27.500High25.760Low107.40KVolume27.190Open27.540Prev Close2.82MTurnover1.79%Turnover RatioLossP/E (Static)15.80MShares37.26652wk High1.74P/B157.05MFloat Cap14.65052wk Low--Dividend TTM6.01MShs Float1115.000Historical High--Div Yield TTM6.32%Range %6.875Historical Low26.220Avg Price1Lot Size
NGNE Stock Chart
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
NGNE Orderflow
Unit: --
NGNE Orderflow Trend
IntradayDayWeekMonth
No Data
Neurogene (NGNE) News
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Analysts Offer Insights on Healthcare Companies: Alpha Tau Medical Ltd (DRTS), Neurogene (NGNE) and Milestone Pharmaceuticals (MIST)
H.C. Wainwright Maintains Neurogene(NGNE.US) With Buy Rating, Maintains Target Price $70
Analyst Reiterates Buy on Neurogene, Maintains $70 Price Target on Promising NGN-401 Profile and Solid Cash Runway
LifeSci Capital Maintains Neurogene(NGNE.US) With Buy Rating, Maintains Target Price $60
Neurogene (NGNE) Stock Forum
$Neurogene (NGNE.US)$ Neurogene Announces FDA Breakthrough Therapy Designation for NGN-401 Gene Therapy for Rett Syndrome
Breakthrough Therapy designation granted based on interim NGN-401 Phase 1/2 data demonstrating clinically meaningful, durable and multidomain functional improvements
On track to complete dosing in Embolden™ registrational trial of NGN-401
in second quarter of 2026
Plans to present additional interim Phase 1/2...
Breakthrough Therapy designation granted based on interim NGN-401 Phase 1/2 data demonstrating clinically meaningful, durable and multidomain functional improvements
On track to complete dosing in Embolden™ registrational trial of NGN-401
in second quarter of 2026
Plans to present additional interim Phase 1/2...
3
This watchlist highlights U.S. stocks showing the strongest short-squeeze setups based on 📊 Relative Volume, 💥 Short Float %, ⏳ Days to Cover, and 📈 Short Volume Ratio. The Pressure Index reveals how trapped short sellers are, while the Squeeze Probability measures the likelihood of a breakout driven by strong trading volume and rising momentum.
💬 Get full list of our Short Squeeze Watchlist on our PEN Stock Alerts Discord 👉 patreon.com/148...
1. APGE - ...
💬 Get full list of our Short Squeeze Watchlist on our PEN Stock Alerts Discord 👉 patreon.com/148...
1. APGE - ...
5
1
This watchlist highlights U.S. stocks showing the strongest short-squeeze setups based on 📊 Relative Volume, 💥 Short Float %, ⏳ Days to Cover, and 📈 Short Volume Ratio. The Pressure Index reveals how trapped short sellers are, while the Squeeze Probability measures the likelihood of a breakout driven by strong trading volume and rising momentum
💬 Get full list of our Short Squeeze Watchlist on our PEN Stock Alerts Discord 👉 patreon.com/148...
1. IMNM IS ...
💬 Get full list of our Short Squeeze Watchlist on our PEN Stock Alerts Discord 👉 patreon.com/148...
1. IMNM IS ...
3
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)